FDA's Makary stacks the deck with conflicted "expert panels"
Promoting "listening sessions" that don't listen to disparate voices| garyschwitzer.substack.com
Promoting "listening sessions" that don't listen to disparate voices| garyschwitzer.substack.com
A recording of the full FDA Panel on SSRIs and Pregnancy is linked to the last post here. There has been extensive media coverage of this event - and 18 takes on what reporters heard can be found linked to Unsafe Safety Systems on RxISK. Roger McFillin was on thin ice, at the recent FDA| Dr. David Healy
Following a media feeding frenzy in the wake of an FDA Panel on SSRIs in Pregnancy - see Unsafe Safety Systems - another feeding frenzy erupted with an HHS (Health and Human Services ) statement that it was reviewing the use of Tylenol in Pregnancy and possible links to Autism. This post engages with both| Dr. David Healy
On behalf of FDA Commissioner Marty Makary, M.D., M.P.H., the FDA is holding a series of roundtable discussions with independent panels of scientific experts that will review the latest scientific evidence, evaluate potential health risks, explore safer alternatives, and may offer recommendations for regulatory action. This initiative is part of the FDA’s broader efforts to| Dr. David Healy
Following the FDA Panel on SSRIs and pregnancy, there have so far been 25 English language US-based media reports and counting. These are reproduced following the UnSafe Safety Systems post. There will likely be more from professional medical groups and medical journals which will be posted after this post. Anything anyone spots would be good […] The post Antidepressants and Pregnancy Adam Urato first appeared on RxISK.| RxISK
On behalf of FDA Commissioner Marty Makary, M.D., M.P.H., the FDA is holding a series of roundtable discussions with independent panels of scientific experts that will review the latest scientific evidence, evaluate potential health risks, explore safer alternatives, and may offer recommendations for regulatory action. This initiative is part of the FDA’s broader efforts to apply| RxISK - Making Medicines Safer for All of Us
